Cargando…
Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People
BACKGROUND: In 2008 the Austrian Task Force for Neuromyelitis Optica (NMO) started a nation-wide network for information exchange and multi-centre collaboration. Their aim was to detect all patients with NMO or NMO spectrum disorders (NMO-SD) in Austria and to analyse their disease courses and respo...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818238/ https://www.ncbi.nlm.nih.gov/pubmed/24223985 http://dx.doi.org/10.1371/journal.pone.0079649 |
_version_ | 1782478160481222656 |
---|---|
author | Aboul-Enein, Fahmy Seifert-Held, Thomas Mader, Simone Kuenz, Bettina Lutterotti, Andreas Rauschka, Helmut Rommer, Paulus Leutmezer, Fritz Vass, Karl Flamm-Horak, Agathe Stepansky, Robert Lang, Wilfried Fertl, Elisabeth Schlager, Thomas Heller, Thomas Eggers, Christian Safoschnik, Georg Fuchs, Siegrid Kraus, Jörg Assar, Hamid Guggenberger, Stefan Reisz, Martin Schnabl, Peter Komposch, Martina Simschitz, Philipp Skrobal, Alena Moser, Alexander Jeschow, Mario Stadlbauer, Dorothea Freimüller, Manfred Guger, Michael Schmidegg, Susanne Franta, Claudia Weiser, Vera Koppi, Stefan Niederkorn-Duft, Margret Raber, Bettina Schmeissner, Iris Jecel, Julia Tinchon, Alexander Storch, Maria K. Reindl, Markus Berger, Thomas Kristoferitsch, Wolfgang |
author_facet | Aboul-Enein, Fahmy Seifert-Held, Thomas Mader, Simone Kuenz, Bettina Lutterotti, Andreas Rauschka, Helmut Rommer, Paulus Leutmezer, Fritz Vass, Karl Flamm-Horak, Agathe Stepansky, Robert Lang, Wilfried Fertl, Elisabeth Schlager, Thomas Heller, Thomas Eggers, Christian Safoschnik, Georg Fuchs, Siegrid Kraus, Jörg Assar, Hamid Guggenberger, Stefan Reisz, Martin Schnabl, Peter Komposch, Martina Simschitz, Philipp Skrobal, Alena Moser, Alexander Jeschow, Mario Stadlbauer, Dorothea Freimüller, Manfred Guger, Michael Schmidegg, Susanne Franta, Claudia Weiser, Vera Koppi, Stefan Niederkorn-Duft, Margret Raber, Bettina Schmeissner, Iris Jecel, Julia Tinchon, Alexander Storch, Maria K. Reindl, Markus Berger, Thomas Kristoferitsch, Wolfgang |
author_sort | Aboul-Enein, Fahmy |
collection | PubMed |
description | BACKGROUND: In 2008 the Austrian Task Force for Neuromyelitis Optica (NMO) started a nation-wide network for information exchange and multi-centre collaboration. Their aim was to detect all patients with NMO or NMO spectrum disorders (NMO-SD) in Austria and to analyse their disease courses and response to treatment. METHODS: (1) As of March 2008, 1957 serum samples (of 1557 patients) have been tested with an established cell based immunofluorescence aquaporin-4 antibody (AQP4-ab) assay with a high sensitivity and specificity (both >95%). All tests were performed in a single reference laboratory (Clinical Dept. of Neurology of the Innsbruck Medical University). (2) A nation-wide survey with several calls for participation (via email newsletters, articles in the official journal of the Austrian Society of Neurology, and workshops) was initiated in 2008. All collected data will be presented in a way that allows that every individual patient can be traced back in order to ensure transparency and to avoid any data distortion in future meta-analyses. The careful and detailed presentation allows the visualization and comparison of the different disease courses in real time span. Failure and response to treatment are made visible at one glance. Database closure was 31 December 2011. All co-operators were offered co-authorship. RESULTS: All 71 NMO- or NMO-SD patients with AQP4-ab positivity (age range 12.3 to 79.6 years) were analysed in detail. Sex ratio (m:f = 1:7) and the proportion of patients without oligoclonal bands in cerebrospinal fluid (86.6%) were in line with previously published results. All identified patients were Caucasians. CONCLUSIONS: A nationwide collaboration amongst Austrian neurologists with good network communications made it possible to establish a database of 71 AQP4-ab positive patients with NMO/NMO-SD. This database is presented in detail and provides the basis for further studies and international cooperation in order to investigate this rare disease. |
format | Online Article Text |
id | pubmed-3818238 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-38182382013-11-09 Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People Aboul-Enein, Fahmy Seifert-Held, Thomas Mader, Simone Kuenz, Bettina Lutterotti, Andreas Rauschka, Helmut Rommer, Paulus Leutmezer, Fritz Vass, Karl Flamm-Horak, Agathe Stepansky, Robert Lang, Wilfried Fertl, Elisabeth Schlager, Thomas Heller, Thomas Eggers, Christian Safoschnik, Georg Fuchs, Siegrid Kraus, Jörg Assar, Hamid Guggenberger, Stefan Reisz, Martin Schnabl, Peter Komposch, Martina Simschitz, Philipp Skrobal, Alena Moser, Alexander Jeschow, Mario Stadlbauer, Dorothea Freimüller, Manfred Guger, Michael Schmidegg, Susanne Franta, Claudia Weiser, Vera Koppi, Stefan Niederkorn-Duft, Margret Raber, Bettina Schmeissner, Iris Jecel, Julia Tinchon, Alexander Storch, Maria K. Reindl, Markus Berger, Thomas Kristoferitsch, Wolfgang PLoS One Research Article BACKGROUND: In 2008 the Austrian Task Force for Neuromyelitis Optica (NMO) started a nation-wide network for information exchange and multi-centre collaboration. Their aim was to detect all patients with NMO or NMO spectrum disorders (NMO-SD) in Austria and to analyse their disease courses and response to treatment. METHODS: (1) As of March 2008, 1957 serum samples (of 1557 patients) have been tested with an established cell based immunofluorescence aquaporin-4 antibody (AQP4-ab) assay with a high sensitivity and specificity (both >95%). All tests were performed in a single reference laboratory (Clinical Dept. of Neurology of the Innsbruck Medical University). (2) A nation-wide survey with several calls for participation (via email newsletters, articles in the official journal of the Austrian Society of Neurology, and workshops) was initiated in 2008. All collected data will be presented in a way that allows that every individual patient can be traced back in order to ensure transparency and to avoid any data distortion in future meta-analyses. The careful and detailed presentation allows the visualization and comparison of the different disease courses in real time span. Failure and response to treatment are made visible at one glance. Database closure was 31 December 2011. All co-operators were offered co-authorship. RESULTS: All 71 NMO- or NMO-SD patients with AQP4-ab positivity (age range 12.3 to 79.6 years) were analysed in detail. Sex ratio (m:f = 1:7) and the proportion of patients without oligoclonal bands in cerebrospinal fluid (86.6%) were in line with previously published results. All identified patients were Caucasians. CONCLUSIONS: A nationwide collaboration amongst Austrian neurologists with good network communications made it possible to establish a database of 71 AQP4-ab positive patients with NMO/NMO-SD. This database is presented in detail and provides the basis for further studies and international cooperation in order to investigate this rare disease. Public Library of Science 2013-11-05 /pmc/articles/PMC3818238/ /pubmed/24223985 http://dx.doi.org/10.1371/journal.pone.0079649 Text en © 2013 Aboul-Enein et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Aboul-Enein, Fahmy Seifert-Held, Thomas Mader, Simone Kuenz, Bettina Lutterotti, Andreas Rauschka, Helmut Rommer, Paulus Leutmezer, Fritz Vass, Karl Flamm-Horak, Agathe Stepansky, Robert Lang, Wilfried Fertl, Elisabeth Schlager, Thomas Heller, Thomas Eggers, Christian Safoschnik, Georg Fuchs, Siegrid Kraus, Jörg Assar, Hamid Guggenberger, Stefan Reisz, Martin Schnabl, Peter Komposch, Martina Simschitz, Philipp Skrobal, Alena Moser, Alexander Jeschow, Mario Stadlbauer, Dorothea Freimüller, Manfred Guger, Michael Schmidegg, Susanne Franta, Claudia Weiser, Vera Koppi, Stefan Niederkorn-Duft, Margret Raber, Bettina Schmeissner, Iris Jecel, Julia Tinchon, Alexander Storch, Maria K. Reindl, Markus Berger, Thomas Kristoferitsch, Wolfgang Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People |
title | Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People |
title_full | Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People |
title_fullStr | Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People |
title_full_unstemmed | Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People |
title_short | Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People |
title_sort | neuromyelitis optica in austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818238/ https://www.ncbi.nlm.nih.gov/pubmed/24223985 http://dx.doi.org/10.1371/journal.pone.0079649 |
work_keys_str_mv | AT abouleneinfahmy neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT seifertheldthomas neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT madersimone neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT kuenzbettina neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT lutterottiandreas neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT rauschkahelmut neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT rommerpaulus neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT leutmezerfritz neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT vasskarl neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT flammhorakagathe neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT stepanskyrobert neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT langwilfried neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT fertlelisabeth neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT schlagerthomas neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT hellerthomas neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT eggerschristian neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT safoschnikgeorg neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT fuchssiegrid neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT krausjorg neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT assarhamid neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT guggenbergerstefan neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT reiszmartin neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT schnablpeter neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT komposchmartina neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT simschitzphilipp neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT skrobalalena neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT moseralexander neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT jeschowmario neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT stadlbauerdorothea neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT freimullermanfred neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT gugermichael neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT schmideggsusanne neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT frantaclaudia neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT weiservera neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT koppistefan neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT niederkornduftmargret neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT raberbettina neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT schmeissneriris neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT jeceljulia neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT tinchonalexander neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT storchmariak neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT reindlmarkus neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT bergerthomas neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople AT kristoferitschwolfgang neuromyelitisopticainaustriain2011tobridgethegapbetweenneuroepidemiologicalresearchandpracticeinastudypopulationof84millionpeople |